US$ 20.11
aod9604 5mg AOD-9604 (5MG) AOD9604 5mg Vial - UPA
Description
Dynotides First order Research supply Save 15% off your first batch

Novel targets for the treatment of obesity: a review of progress

For that purpose, it has several purported benefits

The high NAD+ base carries a concentrated MOTS-c and 5-Amino-1MQ pairing, making it primarily a concentrated MOTS-c / 5-Amino-1MQ blend on an NAD+ foundation

The company launched a Phase 2b trial with the ambition of registering AOD-9604 as an obesity drug

I started off weighing 138lbs and I am now 132lbs towards the tail end of the month
